PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 281 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 6.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $46,000 | -82.8% | 788 | -77.4% | 0.00% | -77.8% |
| Q1 2022 | $267,000 | +154.3% | 3,494 | +99.9% | 0.01% | +125.0% |
| Q4 2021 | $105,000 | +2000.0% | 1,748 | +1800.0% | 0.00% | – |
| Q3 2021 | $5,000 | -98.8% | 92 | -98.6% | 0.00% | -100.0% |
| Q2 2021 | $402,000 | +688.2% | 6,622 | +681.8% | 0.01% | +550.0% |
| Q4 2020 | $51,000 | -64.1% | 847 | -68.7% | 0.00% | -87.5% |
| Q2 2020 | $142,000 | +202.1% | 2,706 | +118.4% | 0.02% | +14.3% |
| Q3 2019 | $47,000 | +113.6% | 1,239 | +145.8% | 0.01% | +133.3% |
| Q2 2019 | $22,000 | – | 504 | +4481.8% | 0.01% | – |
| Q1 2019 | $0 | -100.0% | 11 | -87.8% | 0.00% | -100.0% |
| Q2 2018 | $3,000 | -70.0% | 90 | -72.0% | 0.00% | -80.0% |
| Q1 2018 | $10,000 | -33.3% | 321 | -0.3% | 0.01% | -54.5% |
| Q4 2017 | $15,000 | +275.0% | 322 | +192.7% | 0.01% | +266.7% |
| Q3 2017 | $4,000 | +300.0% | 110 | +423.8% | 0.00% | +200.0% |
| Q2 2017 | $1,000 | -97.6% | 21 | -97.7% | 0.00% | -98.2% |
| Q1 2017 | $42,000 | – | 931 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |